<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">BMC Musculoskelet Disord</journal-id><journal-title>BMC Musculoskeletal Disorders</journal-title><issn pub-type="epub">1471-2474</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">16545120</article-id><article-id pub-id-type="pmc">1431535</article-id><article-id pub-id-type="publisher-id">1471-2474-7-31</article-id><article-id pub-id-type="doi">10.1186/1471-2474-7-31</article-id><article-categories><subj-group subj-group-type="heading"><subject>Study Protocol</subject></subj-group></article-categories><title-group><article-title>The PEX study – Exercise therapy for patellofemoral pain syndrome: design of a randomized clinical trial in general practice and sports medicine [ISRCTN83938749]</article-title></title-group><contrib-group><contrib id="A1" corresp="yes" contrib-type="author"><name><surname>van Linschoten</surname><given-names>Robbart</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>r.v.linschoten@hccnet.nl</email></contrib><contrib id="A2" contrib-type="author"><name><surname>van Middelkoop</surname><given-names>Marienke</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>m.vanmiddelkoop@erasmusmc.nl</email></contrib><contrib id="A3" contrib-type="author"><name><surname>Berger</surname><given-names>Marjolein Y</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>m.berger@erasmusmc.nl</email></contrib><contrib id="A4" contrib-type="author"><name><surname>Heintjes</surname><given-names>Edith M</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>e.heintjes@erasmusmc.nl</email></contrib><contrib id="A5" contrib-type="author"><name><surname>Koopmanschap</surname><given-names>Mark A</given-names></name><xref ref-type="aff" rid="I3">3</xref><email>m.koopmanschap@erasmusmc.nl</email></contrib><contrib id="A6" contrib-type="author"><name><surname>Verhaar</surname><given-names>Jan AN</given-names></name><xref ref-type="aff" rid="I2">2</xref><email>j.verhaar@erasmusmc.nl</email></contrib><contrib id="A7" contrib-type="author"><name><surname>Koes</surname><given-names>Bart W</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>b.koes@erasmusmc.nl</email></contrib><contrib id="A8" contrib-type="author"><name><surname>Bierma-Zeinstra</surname><given-names>Sita MA</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>s.bierma-zeinstra@erasmusmc.nl</email></contrib></contrib-group><aff id="I1"><label>1</label>Department of General Practice, Erasmus MC, University Medical Centre, Rotterdam, The Netherlands</aff><aff id="I2"><label>2</label>Department of Orthopedics, Erasmus MC, University Medical Centre Rotterdam, The Netherlands</aff><aff id="I3"><label>3</label>iMTA, Erasmus MC, University Medical Centre Rotterdam, The Netherlands</aff><pub-date pub-type="collection"><year>2006</year></pub-date><pub-date pub-type="epub"><day>17</day><month>3</month><year>2006</year></pub-date><volume>7</volume><fpage>31</fpage><lpage>31</lpage><ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-2474/7/31"></ext-link><history><date date-type="received"><day>13</day><month>1</month><year>2006</year></date><date date-type="accepted"><day>17</day><month>3</month><year>2006</year></date></history><copyright-statement>Copyright © 2006 van Linschoten et al; licensee BioMed Central Ltd.</copyright-statement><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0"><p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0"></ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p></license><abstract><sec><title><offsets xml_i="4058" xml_f="4068" txt_i="11" txt_f="21">Background</offsets></title><p><offsets xml_i="4079" xml_f="4347" txt_i="22" txt_f="290">Patellofemoral complaints are frequently seen in younger and active patients. Clinical strategy is usually based on decreasing provoking activities as sports and demanding knee activities during work and leisure and reassuring the patient on the presumed good outcome.</offsets></p><p><offsets xml_i="4354" xml_f="4442" txt_i="291" txt_f="379">Exercise therapy is also often prescribed although evidence on effectiveness is lacking.</offsets></p><p><offsets xml_i="4449" xml_f="4720" txt_i="380" txt_f="651">The objective of this article is to present the design of a randomized clinical trial that examines the outcome of exercise therapy supervised by a physical therapist versus a clinically accepted "wait and see" approach (information and advice about the complaints only).</offsets></p><p><offsets xml_i="4727" xml_f="4882" txt_i="652" txt_f="807">The research will address to both effectiveness and cost effectiveness of supervised exercise therapy in patients with patellofemoral pain syndrome (PFPS).</offsets></p></sec><sec><title><offsets xml_i="4904" xml_f="4918" txt_i="809" txt_f="823">Methods/design</offsets></title><p><offsets xml_i="4929" xml_f="5163" txt_i="824" txt_f="1058">136 patients (adolescents and young adults) with patellofemoral pain syndrome are recruited in general practices and sport medicine centers. They will be randomly allocated receiving either 3 months of exercise therapy (or usual care.</offsets></p><p><offsets xml_i="5170" xml_f="5331" txt_i="1059" txt_f="1220">The primary outcome measures are pain, knee function and perception of recovery after 3 months and 12 months of follow up and will be measured by self reporting.</offsets></p><p><offsets xml_i="5338" xml_f="5445" txt_i="1221" txt_f="1328">Measurements will take place at baseline, 6 weeks, and 3 monthly until 1 year after inclusion in the study.</offsets></p><p><offsets xml_i="5452" xml_f="5514" txt_i="1329" txt_f="1391">Secondary outcome measurements include an economic evaluation.</offsets></p><p><offsets xml_i="5521" xml_f="5697" txt_i="1392" txt_f="1568">A cost-utility analysis will be performed that expresses health improvements in Quality Adjusted Life Years (QALYs) and incorporates direct medical costs and productivity costs</offsets></p></sec><sec><title><offsets xml_i="5719" xml_f="5729" txt_i="1570" txt_f="1580">Discussion</offsets></title><p><offsets xml_i="5740" xml_f="5986" txt_i="1581" txt_f="1827">This study has been designed after reviewing the literature on exercise therapy for patellofemoral pain syndrome. It was concluded that to merit the effect of exercise therapy a trial based on correct methodological concept needed to be executed.</offsets></p><p><offsets xml_i="5993" xml_f="6208" txt_i="1828" txt_f="2043">The PEX study is a randomized clinical trial where exercise therapy is compared to usual care. This trial started in April 2005 and will finish in June 2007. The first results will be available around December 2007.</offsets></p></sec></abstract></article-meta></front><body><sec><title><offsets xml_i="6270" xml_f="6280" txt_i="2052" txt_f="2062">Background</offsets></title><p><offsets xml_i="6291" xml_f="6498" txt_i="2063" txt_f="2270">Patellofemoral pain syndrome (PFPS) is a common complaint in adolescents and younger adults. Though exact epidemiological data do not exist, 5–6 six new cases per year in Dutch GP-practices may be expected [</offsets><xref ref-type="bibr" rid="B1"><offsets xml_i="6529" xml_f="6530" txt_i="2270" txt_f="2271">1</offsets></xref><offsets xml_i="6537" xml_f="6771" txt_i="2271" txt_f="2505">]. The symptom most frequently reported is a diffuse peripatellar and retropatellar localized pain, typically provoked by ascending or descending stairs, squatting, cycling and sitting with flexed knees for prolonged periods of time [</offsets><xref ref-type="bibr" rid="B2"><offsets xml_i="6802" xml_f="6803" txt_i="2505" txt_f="2506">2</offsets></xref><offsets xml_i="6810" xml_f="6811" txt_i="2506" txt_f="2507">,</offsets><xref ref-type="bibr" rid="B3"><offsets xml_i="6842" xml_f="6843" txt_i="2507" txt_f="2508">3</offsets></xref><offsets xml_i="6850" xml_f="7268" txt_i="2508" txt_f="2926">]. Weakness of the knee extensors and abnormal firing patterns of the nerves innervating these knee extensors have been found in patients with PFPS. These phenomena are thought to cause maltracking of the patella through the femoral groove, resulting in increased intrapatellar pressure. Tight anatomical structures and heavy physical loading may add to the pressure. This pressure probably causes patellofemoral pain.</offsets></p><p><offsets xml_i="7275" xml_f="7383" txt_i="2927" txt_f="3035">PFPS frequently becomes a chronic problem, forcing the patient to stop sports and other similar activities [</offsets><xref ref-type="bibr" rid="B4"><offsets xml_i="7414" xml_f="7415" txt_i="3035" txt_f="3036">4</offsets></xref><offsets xml_i="7422" xml_f="7572" txt_i="3036" txt_f="3186">]. The long-term prognosis is generally more favorable for young patients, but seems to be independent of the presence of cartilage damage or gender [</offsets><xref ref-type="bibr" rid="B5"><offsets xml_i="7603" xml_f="7604" txt_i="3186" txt_f="3187">5</offsets></xref><offsets xml_i="7611" xml_f="7613" txt_i="3187" txt_f="3189">].</offsets></p><p><offsets xml_i="7620" xml_f="7687" txt_i="3190" txt_f="3257">Clinical guidelines of the Dutch College of General Practitioners [</offsets><xref ref-type="bibr" rid="B6"><offsets xml_i="7718" xml_f="7719" txt_i="3257" txt_f="3258">6</offsets></xref><offsets xml_i="7726" xml_f="8736" txt_i="3258" txt_f="4268">] advise GPs to inform the patient about the background of the condition and its favorable prognosis. Patients are advised to refrain from all (sports-) activities that provoke pain, and to find alternative exercises to keep in shape. Non-weight bearing quadriceps strengthening exercises may be considered, but the guidelines explicitly mention that evidence for its effectiveness is lacking. Patellar taping is not advised. In case of prolonged unresponsive, severe complaints, referral to an orthopedic surgeon may be considered. General practitioners do not always adhere to these guidelines and prescriptions for analgesics such as paracetamol and NSAIDs to reduce pain and referrals to physical therapists (exercise therapy) are among the treatments regularly encountered (unpublished data authors). People involved in sports and athletic activities may consult sports clinics with their symptoms. In sports clinics it is more common to refer to physical therapy for exercises (unpublished data authors).</offsets></p><p><offsets xml_i="8743" xml_f="8832" txt_i="4269" txt_f="4358">Evidence for the effectiveness of conservative therapies for PFPS is scarcely available [</offsets><xref ref-type="bibr" rid="B2"><offsets xml_i="8863" xml_f="8864" txt_i="4358" txt_f="4359">2</offsets></xref><offsets xml_i="8871" xml_f="9043" txt_i="4359" txt_f="4531">]. Exercise therapy is based on the theoretical assumption that muscle weakness or imbalance is a major contributor in the development of PFPS. The recent Cochrane review [</offsets><xref ref-type="bibr" rid="B7"><offsets xml_i="9074" xml_f="9075" txt_i="4531" txt_f="4532">7</offsets></xref><offsets xml_i="9082" xml_f="9210" txt_i="4532" txt_f="4660">] performed by our group identified only 3 trials comparing exercise therapy with a control group not receiving exercise therapy</offsets></p><p><offsets xml_i="9217" xml_f="9381" txt_i="4661" txt_f="4825">We found limited evidence that exercise was beneficial, though the quality of the trials was such that further research was recommended to confirm this conclusion [</offsets><xref ref-type="bibr" rid="B7"><offsets xml_i="9412" xml_f="9413" txt_i="4825" txt_f="4826">7</offsets></xref><offsets xml_i="9420" xml_f="9810" txt_i="4826" txt_f="5216">]. Recently a small placebo controlled trial was published investigating the short-term effectiveness of exercise therapy combined with taping and passive manual mobilization of the patella. The control group received sham ultrasound and placebo-taping. The authors reported beneficial effects in the intervention group (n = 33) compared the control group (n = 34) after 6 weeks follow-up [</offsets><xref ref-type="bibr" rid="B8"><offsets xml_i="9841" xml_f="9842" txt_i="5216" txt_f="5217">8</offsets></xref><offsets xml_i="9849" xml_f="9901" txt_i="5217" txt_f="5269">]. Cost effectiveness data are not available at all.</offsets></p><p><offsets xml_i="9908" xml_f="10374" txt_i="5270" txt_f="5736">Because physicians, especially the GP and sports physician, frequently are confronted with patients with PFPS, but by lack of evidence are unable to apply the most (cost)effective treatment, a randomized intervention study is highly indicated. The 'wait and see' policy advocated in the guidelines should be compared to the more active approach of exercise therapy under supervision of a physical therapist, in order to assess (cost)effectiveness of both approaches.</offsets></p><p><offsets xml_i="10381" xml_f="10578" txt_i="5737" txt_f="5934">The trial will target patients (adolescents and young adults) presenting in general practice and sports clinics with the symptoms of PFPS and no history of previous active treatment with exercises.</offsets></p><p><offsets xml_i="10585" xml_f="10652" txt_i="5935" txt_f="6002">In this article we will present the detailed protocol of the trial.</offsets></p><p><offsets xml_i="10659" xml_f="10735" txt_i="6003" txt_f="6079">This trial started April 2005 and patients will be included until June 2006.</offsets></p></sec><sec><title><offsets xml_i="10757" xml_f="10771" txt_i="6081" txt_f="6095">Methods/design</offsets></title><sec><title><offsets xml_i="10791" xml_f="10803" txt_i="6096" txt_f="6108">Study design</offsets></title><p><offsets xml_i="10814" xml_f="11082" txt_i="6109" txt_f="6377">This study is a randomized clinical trial to study short-term and long-term (cost) effectiveness of exercise therapy in combination with advice and information on the background of PFPS compared to advice and information on the background of PFPS only ("wait and see")</offsets></p><p><offsets xml_i="11089" xml_f="11114" txt_i="6378" txt_f="6403">The study design (Figure </offsets><xref ref-type="fig" rid="F1"><offsets xml_i="11144" xml_f="11145" txt_i="6403" txt_f="6404">1</offsets></xref><offsets xml_i="11152" xml_f="11299" txt_i="6404" txt_f="6551">) was approved by the Medical Ethics Committee at the Erasmus MC – university medical centre Rotterdam. All patients gave written informed consent.</offsets></p></sec><sec><title><offsets xml_i="11321" xml_f="11338" txt_i="6553" txt_f="6570">Patient selection</offsets></title><p><offsets xml_i="11349" xml_f="11787" txt_i="6571" txt_f="7009">Patients eligible for this trial are adolescents and young adults in the age of 14 to 40 years consulting the GP or sports physician for PFPS lasting longer than two months but not longer than 2 years. Recruitment will take place in "HONEUR" practices (a research network of 38 general practices allied with the Department of General Practice of Erasmus MC) and in 4 sports medical centers in Rotterdam, Leidschendam, Breda and Gorinchem.</offsets></p><p><offsets xml_i="11794" xml_f="11860" txt_i="7010" txt_f="7076">The recruitment period is planned from April 2005 until June 2006.</offsets></p></sec><sec><title><offsets xml_i="11882" xml_f="11908" txt_i="7078" txt_f="7104">In- and exclusion criteria</offsets></title><p><offsets xml_i="11919" xml_f="11976" txt_i="7105" txt_f="7162">Inclusion criteria are the following diagnostic criteria;</offsets></p><p><offsets xml_i="11983" xml_f="12285" txt_i="7163" txt_f="7465">Presence of at least 3 symptoms of the following: pain when walking stairs, pain when squatting, pain when running, pain when cycling, pain when sitting with knees flexed for a prolonged period of time, grinding of the patella, positive physical tests (Clarke's test, Rabot sign, patella release test).</offsets></p><p><offsets xml_i="12292" xml_f="12489" txt_i="7466" txt_f="7663">The exclusion criteria are: knee osteoarthrosis/arthritis, previous knee injury or knee operations, patellar tendinopathy, M. Osgood Schlatter, or other defined pathological conditions of the knee.</offsets></p></sec><sec><title><offsets xml_i="12511" xml_f="12522" txt_i="7665" txt_f="7676">Sample size</offsets></title><p><offsets xml_i="12533" xml_f="12600" txt_i="7677" txt_f="7744">Sample size is based on studies included in our systematic review [</offsets><xref ref-type="bibr" rid="B7"><offsets xml_i="12631" xml_f="12632" txt_i="7744" txt_f="7745">7</offsets></xref><offsets xml_i="12639" xml_f="12711" txt_i="7745" txt_f="7817">]. In a single study investigating a similar contrast of interventions [</offsets><xref ref-type="bibr" rid="B9"><offsets xml_i="12742" xml_f="12743" txt_i="7817" txt_f="7818">9</offsets></xref><offsets xml_i="12750" xml_f="13245" txt_i="7818" txt_f="8313">] there was an absolute increase in recovery of 22% (19% recovery in the usual care group to 41% recovery in the exercise therapy group) after one year, OR 2.21 (95%CI 0.87 – 5.64)). This represents a clinically relevant increase and is expected to be even more pronounced after 3 months follow-up. Such a difference can be detected statistically (power 0.80, alpha 0.05 one-sided test) with 61 patients per group. With a potential dropout rate of 10% a total of 136 patients should be included.</offsets></p></sec><sec><title><offsets xml_i="13267" xml_f="13279" txt_i="8315" txt_f="8327">Intervention</offsets></title><p><offsets xml_i="13290" xml_f="13348" txt_i="8328" txt_f="8386">The interventions that will be compared in this trial are:</offsets></p><p><offsets xml_i="13355" xml_f="13846" txt_i="8387" txt_f="8878">A) Exercise therapy for a period of 6 weeks, provided by a physical therapist according to a standardized protocol drawn up according to present international expert opinion and modified by local participating physical therapists into a practical protocol which is feasible in daily practice. The program consists of static and dynamic muscular exercises for quadriceps muscles, balance exercises and flexibility exercises. Patients are directed to practice 7 times a week during 20 minutes.</offsets></p><p><offsets xml_i="13853" xml_f="13935" txt_i="8879" txt_f="8961">Instructions concerning the exercises will be noted on the "workout book" (Figure </offsets><xref ref-type="fig" rid="F2"><offsets xml_i="13965" xml_f="13966" txt_i="8961" txt_f="8962">2</offsets></xref><offsets xml_i="13973" xml_f="14140" txt_i="8962" txt_f="9129">) which has been designed for the study. The notes regarding frequency and duration of exercises is send to the investigators after the three month period of exercise.</offsets></p><p><offsets xml_i="14147" xml_f="14382" txt_i="9130" txt_f="9365">Patients will receive standardized information about the background and prognosis of PFPS on a specially designed leaflet. After the period of 6 weeks patients will be advised to keep up the exercises at home for the following 6 weeks.</offsets></p><p><offsets xml_i="14389" xml_f="14738" txt_i="9366" txt_f="9715">B) The control group will receive the standardized information and advice. This advice consists of the information usually given by GPs, according to the guidelines: information about the background of the condition and its good prognosis, advice to refrain from all (sports-) activities that provoke pain, and to find alternatives to keep in shape.</offsets></p><p><offsets xml_i="14745" xml_f="14856" txt_i="9716" txt_f="9827">An information leaflet for the patients has been compiled to contribute to the standardization for both groups.</offsets></p><sec><title><offsets xml_i="14872" xml_f="14888" txt_i="9828" txt_f="9844">Co-interventions</offsets></title><p><offsets xml_i="14899" xml_f="15291" txt_i="9845" txt_f="10237">During the one year follow-up other interventions like the use of ice applications, bandages or braces, or consumption of oral analgesics (NSAIDs or paracetamol) indicated by pain severity are allowed for both groups. Information about these co-interventions will be collected after 6 weeks and every 3 months and during one year follow-up and will be used in the cost-effectiveness analysis.</offsets></p></sec></sec><sec><title><offsets xml_i="15319" xml_f="15332" txt_i="10240" txt_f="10253">Randomization</offsets></title><p><offsets xml_i="15343" xml_f="15546" txt_i="10254" txt_f="10457">After recruitment through the participating GP's and sport physicians the patient is finally accepted in the study after written informed consent and reassessment of the inclusion and exclusion criteria.</offsets></p><p><offsets xml_i="15553" xml_f="15725" txt_i="10458" txt_f="10630">Following this informed consent and baseline assessments, patients are allocated to the intervention or control group using a blinded and computer based randomization list.</offsets></p><p><offsets xml_i="15732" xml_f="16119" txt_i="10631" txt_f="11018">The randomization table will be stratified for the setting (general practice versus sports clinic) and for age (14–18 versus 19–40). Patient are informed about the treatment allocation and subsequently the patients in the exercise group receive their treatment from a physical therapist in a predetermined centre, whereas patients in the control group will not receive this intervention.</offsets></p></sec><sec><title><offsets xml_i="16141" xml_f="16153" txt_i="11020" txt_f="11032">Measurements</offsets></title><sec><title><offsets xml_i="16173" xml_f="16191" txt_i="11033" txt_f="11051">Outcome parameters</offsets></title><p><offsets xml_i="16202" xml_f="16290" txt_i="11052" txt_f="11140">Primary outcome measures are: perceived recovery (measured with a 7 point Likert scale [</offsets><xref ref-type="bibr" rid="B10"><offsets xml_i="16322" xml_f="16324" txt_i="11140" txt_f="11142">10</offsets></xref><offsets xml_i="16331" xml_f="16428" txt_i="11142" txt_f="11239">] functional disability using a disease-specific disability scale (Kujala Patellofemoral Scale) [</offsets><xref ref-type="bibr" rid="B11"><offsets xml_i="16460" xml_f="16462" txt_i="11239" txt_f="11241">11</offsets></xref><offsets xml_i="16469" xml_f="16522" txt_i="11241" txt_f="11294">] and a pain severity using a numerical rating scale[</offsets><xref ref-type="bibr" rid="B12"><offsets xml_i="16554" xml_f="16556" txt_i="11294" txt_f="11296">12</offsets></xref><offsets xml_i="16563" xml_f="16608" txt_i="11296" txt_f="11341">] after 3 and 12 months of follow-up. (Table </offsets><xref ref-type="table" rid="T1"><offsets xml_i="16640" xml_f="16641" txt_i="11341" txt_f="11342">1</offsets></xref><offsets xml_i="16648" xml_f="16649" txt_i="11342" txt_f="11343">)</offsets></p><p><offsets xml_i="16656" xml_f="16801" txt_i="11344" txt_f="11489">Secondary outcome measures are cost-effectiveness after one year, the primary outcome parameters at 6 weeks follow-up, quality of life (Euroqol)[</offsets><xref ref-type="bibr" rid="B13"><offsets xml_i="16833" xml_f="16835" txt_i="11489" txt_f="11491">13</offsets></xref><offsets xml_i="16842" xml_f="17206" txt_i="11491" txt_f="11855">] and a numerical rating scale (NRS 0–10) for difficulties encountered during work, school or sports activities. Medical consumption (visits to health care providers and consumptions of prescription or over the counter medication), absence from work or decreased productivity at work, and other indirect an direct costs are all included in the economic evaluation.</offsets></p><p><offsets xml_i="17213" xml_f="17504" txt_i="11856" txt_f="12147">Baseline and follow-up questionnaires at 6 weeks and 3 and 12 months will be filled out by the patients themselves. Quality of life, direct costs and productivity costs and compliance to the interventions will be measured after 6 weeks and every 3 months during one year also by self report.</offsets></p></sec></sec><sec><title><offsets xml_i="17532" xml_f="17540" txt_i="12150" txt_f="12158">Analyses</offsets></title><p><offsets xml_i="17551" xml_f="17653" txt_i="12159" txt_f="12261">All analyses will take place after the trial has finished, no intermediate analyses will be performed.</offsets></p><p><offsets xml_i="17660" xml_f="18315" txt_i="12262" txt_f="12917">To evaluate the effectiveness of supervised exercise therapy in patients with PFPS differences in clinical outcome measures between intervention and control group will be analyzed on the basis of intention to treat. Additionally, analysis per protocol will be conducted. Dichotomous outcomes at three and 12 months follow-up will be analyzed using logistic regression techniques and continuous outcomes with linear regression techniques. Of the primary outcomes perceived recovery will be dichotomized to recovered (fully, strongly) or not recovered (slightly-strongly worsened). Other primary outcome measurements will be analyzed as continuous variables</offsets></p><p><offsets xml_i="18322" xml_f="18524" txt_i="12918" txt_f="13120">Analyses will be adjusted for baseline values and for co-interventions and possible prognostic factors in case the effect estimate changes with more than 10% when including these variables in the model.</offsets></p><p><offsets xml_i="18531" xml_f="18649" txt_i="13121" txt_f="13239">Additionally the overall one year dichotomous outcomes will be analyzed using GEE (generalized estimating equations) [</offsets><xref ref-type="bibr" rid="B14"><offsets xml_i="18681" xml_f="18683" txt_i="13239" txt_f="13241">14</offsets></xref><offsets xml_i="18690" xml_f="18875" txt_i="13241" txt_f="13426">], continuous outcomes will be analyzed using linear regression for repeated measurements. Both techniques take the correlation of multiple measurements within one patient into account.</offsets></p><p><offsets xml_i="18882" xml_f="19033" txt_i="13427" txt_f="13578">Research question 2 "What is the cost-effectiveness of supervised exercise therapy in patients with PFPS...." is the basis for the economic evaluation.</offsets></p><p><offsets xml_i="19040" xml_f="19275" txt_i="13579" txt_f="13814">In the economic evaluation (a cost utility analysis) both the costs and the consequences of both treatment options are compared and incremental costs and incremental health effects the latter (in terms of quality of life) is estimated.</offsets></p><p><offsets xml_i="19282" xml_f="19850" txt_i="13815" txt_f="14383">The economic evaluation is performed alongside the randomized clinical trial. Patients will complete questionnaires for costs and quality of life after 6 weeks and every 3 months. Only if the difference in health between the treatment arms appears not to be stable over time, an additional modeling study using a Markov model will be performed. Statistical methods are used to describe uncertainty in costs and effects estimates based on patient data. A 95% confidence interval for the cost-utility ratio will be calculated and an acceptability curve will be presented</offsets></p></sec><sec><title><offsets xml_i="19872" xml_f="19885" txt_i="14385" txt_f="14398">Cost-analysis</offsets></title><p><offsets xml_i="19896" xml_f="20040" txt_i="14399" txt_f="14543">For the economic evaluation a societal perspective is employed. The relevant costs are divided into direct medical costs and productivity costs.</offsets></p><sec><title><offsets xml_i="20056" xml_f="20070" txt_i="14544" txt_f="14558">- Direct costs</offsets></title><p><offsets xml_i="20081" xml_f="20648" txt_i="14559" txt_f="15126">The costs of health care utilization during the twelve months follow-up consist of visits to a general practitioner, medical specialist, physiotherapist, manual therapist, prescribed and over the counter (OTC) medicines, alternative practitioners and hospitalization and appliances. In the patient questionnaire we ask for the health care consumption in the past six weeks. The costs for the period between two measurements (mostly 3 months) are established through linear interpolation. The medical consumption is valued based on resource costs and guideline costs [</offsets><xref ref-type="bibr" rid="B15"><offsets xml_i="20680" xml_f="20682" txt_i="15126" txt_f="15128">15</offsets></xref><offsets xml_i="20689" xml_f="20690" txt_i="15128" txt_f="15129">]</offsets></p></sec><sec><title><offsets xml_i="20712" xml_f="20732" txt_i="15131" txt_f="15151">- Productivity costs</offsets></title><p><offsets xml_i="20743" xml_f="20874" txt_i="15152" txt_f="15283">The productivity costs are defined as the costs of absence from work due to PFPS, including the impact of compensation mechanisms [</offsets><xref ref-type="bibr" rid="B16"><offsets xml_i="20906" xml_f="20908" txt_i="15283" txt_f="15285">16</offsets></xref><offsets xml_i="20915" xml_f="21119" txt_i="15285" txt_f="15489">] the costs of efficiency loss due to PFPS and the costs of hindrance at unpaid work. In the questionnaire the patients are asked to report the reason for absence from work and the number of absent days [</offsets><xref ref-type="bibr" rid="B17"><offsets xml_i="21151" xml_f="21153" txt_i="15489" txt_f="15491">17</offsets></xref><offsets xml_i="21160" xml_f="21214" txt_i="15491" txt_f="15545">]. To this end we will use the PRODISQ questionnaire [</offsets><xref ref-type="bibr" rid="B18"><offsets xml_i="21246" xml_f="21248" txt_i="15545" txt_f="15547">18</offsets></xref><offsets xml_i="21255" xml_f="21393" txt_i="15547" txt_f="15685">]. The valuation of an hour work the average productivity costs per hour worked will be based on the Net National Income per working hour[</offsets><xref ref-type="bibr" rid="B15"><offsets xml_i="21425" xml_f="21427" txt_i="15685" txt_f="15687">15</offsets></xref><offsets xml_i="21434" xml_f="21524" txt_i="15687" txt_f="15777">]. The friction cost method is used to value the productivity costs related to paid work [</offsets><xref ref-type="bibr" rid="B19"><offsets xml_i="21556" xml_f="21558" txt_i="15777" txt_f="15779">19</offsets></xref><offsets xml_i="21565" xml_f="21822" txt_i="15779" txt_f="16036">]. Productivity costs can also occur when people with health complaints are still working, but at a lower productivity level. This is called efficiency loss. The efficiency losses without absence are established by means of the Quality and Quantity-method [</offsets><xref ref-type="bibr" rid="B13"><offsets xml_i="21854" xml_f="21856" txt_i="16036" txt_f="16038">13</offsets></xref><offsets xml_i="21863" xml_f="22185" txt_i="16038" txt_f="16360">]. Productivity losses at unpaid work are assessed by hindrance at unpaid work and the number of hours that housekeeping tasks were taken over by other people, and for how many hours paid help was needed. The costs of one hour of housekeeping tasks is set at the current price of one hour of simple professional home care.</offsets></p></sec><sec><title><offsets xml_i="22207" xml_f="22260" txt_i="16362" txt_f="16415">- Patient outcome analysis in the economic evaluation</offsets></title><p><offsets xml_i="22271" xml_f="22406" txt_i="16416" txt_f="16551">The patellar pain may affect Health Related Quality of Life. This is measured with a generic instrument, the EuroQol instrument EQ-5D [</offsets><xref ref-type="bibr" rid="B20"><offsets xml_i="22438" xml_f="22440" txt_i="16551" txt_f="16553">20</offsets></xref><offsets xml_i="22447" xml_f="22448" txt_i="16553" txt_f="16554">,</offsets><xref ref-type="bibr" rid="B21"><offsets xml_i="22480" xml_f="22482" txt_i="16554" txt_f="16556">21</offsets></xref><offsets xml_i="22489" xml_f="22974" txt_i="16556" txt_f="17041">] The EQ-5D descriptive system consists of five dimensions (Mobility, Self Care, Usual Activities, Pain/Discomfort and Anxiety/Depression) with three levels each (no problems, some problems and extreme problems), thus defining 243 (35) distinct health states. Respondents of the EuroQol EQ-5D describe their own health using this descriptive system. Preference weights based on the Time Trade-Off method for the 243 EQ-5D health states are available from a large-scale study in the UK[</offsets><xref ref-type="bibr" rid="B20"><offsets xml_i="23006" xml_f="23008" txt_i="17041" txt_f="17043">20</offsets></xref><offsets xml_i="23015" xml_f="23016" txt_i="17043" txt_f="17044">,</offsets><xref ref-type="bibr" rid="B21"><offsets xml_i="23048" xml_f="23050" txt_i="17044" txt_f="17046">21</offsets></xref><offsets xml_i="23057" xml_f="23084" txt_i="17046" txt_f="17073">]and a recent Dutch study [</offsets><xref ref-type="bibr" rid="B22"><offsets xml_i="23116" xml_f="23118" txt_i="17073" txt_f="17075">22</offsets></xref><offsets xml_i="23125" xml_f="23208" txt_i="17075" txt_f="17158">] to calculate EQ-5D index scores that can be used as utilities to calculate QALYs.</offsets></p></sec></sec></sec><sec><title><offsets xml_i="23242" xml_f="23252" txt_i="17162" txt_f="17172">Discussion</offsets></title><p><offsets xml_i="23263" xml_f="23380" txt_i="17173" txt_f="17290">The PEX-study has been designed after reviewing the literature on exercise therapy for patellofemoral pain syndrome [</offsets><xref ref-type="bibr" rid="B7"><offsets xml_i="23411" xml_f="23412" txt_i="17290" txt_f="17291">7</offsets></xref><offsets xml_i="23419" xml_f="23621" txt_i="17291" txt_f="17493">]. It was concluded that though exercise therapy may have a beneficial effect on PFPS the scientific evidence is limited due to small sample size and a small amount of studies including a control group.</offsets></p><p><offsets xml_i="23628" xml_f="23820" txt_i="17494" txt_f="17686">Based on available literature our research group expects to discover (beneficial) changes from exercise therapy in perceived recovery, pain severity and functional disability in the PEX study.</offsets></p><p><offsets xml_i="23827" xml_f="24051" txt_i="17687" txt_f="17911">The PEX study is a randomized clinical trial where exercise therapy is compared to usual care. The trial started in April 2005 and is expected to finish in June 2007. The first results will be available around December 2007.</offsets></p></sec><sec><title><offsets xml_i="24073" xml_f="24092" txt_i="17913" txt_f="17932">Competing interests</offsets></title><p><offsets xml_i="24103" xml_f="24163" txt_i="17933" txt_f="17993">The author(s) declare that they have no competing interests.</offsets></p></sec><sec><title><offsets xml_i="24185" xml_f="24207" txt_i="17995" txt_f="18017">Authors' contributions</offsets></title><p><offsets xml_i="24218" xml_f="24550" txt_i="18018" txt_f="18350">SMABZ, BWK and EMH conceived of the study, developed the design of this trial and contributed to the content of the article. MAK, JANV and MYB participated in the design of the study. RL participated in the design and coordination of the study and wrote the article. MM coordinates the trial and is responsible for data acquisition.</offsets></p><p><offsets xml_i="24557" xml_f="24605" txt_i="18351" txt_f="18399">All authors read and approved the final article.</offsets></p></sec><sec><title><offsets xml_i="24627" xml_f="24650" txt_i="18401" txt_f="18424">Pre-publication history</offsets></title><p><offsets xml_i="24661" xml_f="24725" txt_i="18425" txt_f="18489">The pre-publication history for this paper can be accessed here:</offsets></p><p><ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-2474/7/31/prepub"></ext-link></p></sec></body><back><ack><sec><title>Acknowledgements</title><p>The PEX study was funded by a grant of ZON-MW (945-04-356).</p></sec></ack><ref-list><ref id="B1"><citation citation-type="book"><person-group person-group-type="author"><name><surname>Van der Velden</surname><given-names>J</given-names></name></person-group><source>Een nationale studie naar ziekten en verrichtingen in de huisartspraktijk. Basisrapport: morbiditeit in de huisartspraktijk. .</source><year>1991</year><publisher-name>Utrecht:, NIVEL</publisher-name></citation></ref><ref id="B2"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Arroll</surname><given-names>B</given-names></name><name><surname>Ellis-Pegler</surname><given-names>E</given-names></name><name><surname>Edwards</surname><given-names>A</given-names></name><name><surname>Sutcliffe</surname><given-names>G</given-names></name></person-group><article-title>Patellofemoral pain syndrome. A critical review of the clinical trials on nonoperative therapy</article-title><source>Am J Sports Med</source><year>1997</year><volume>25</volume><fpage>207</fpage><lpage>212</lpage><pub-id pub-id-type="pmid">9079175</pub-id></citation></ref><ref id="B3"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cutbill</surname><given-names>JW</given-names></name><name><surname>Ladly</surname><given-names>KO</given-names></name><name><surname>Bray</surname><given-names>RC</given-names></name><name><surname>Thorne</surname><given-names>P</given-names></name><name><surname>Verhoef</surname><given-names>M</given-names></name></person-group><article-title>Anterior knee pain: a review</article-title><source>Clin J Sport Med</source><year>1997</year><volume>7</volume><fpage>40</fpage><lpage>45</lpage><pub-id pub-id-type="pmid">9117525</pub-id></citation></ref><ref id="B4"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Witvrouw</surname><given-names>E</given-names></name><name><surname>Lysens</surname><given-names>R</given-names></name><name><surname>Bellemans</surname><given-names>J</given-names></name><name><surname>Cambier</surname><given-names>D</given-names></name><name><surname>Vanderstraeten</surname><given-names>G</given-names></name></person-group><article-title>Intrinsic risk factors for the development of anterior knee pain in an athletic population. A two-year prospective study</article-title><source>Am J Sports Med</source><year>2000</year><volume>28</volume><fpage>480</fpage><lpage>489</lpage><pub-id pub-id-type="pmid">10921638</pub-id></citation></ref><ref id="B5"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Natri</surname><given-names>A</given-names></name><name><surname>Kannus</surname><given-names>P</given-names></name><name><surname>Jarvinen</surname><given-names>M</given-names></name></person-group><article-title>Which factors predict the long-term outcome in chronic patellofemoral pain syndrome? A 7-yr prospective follow-up study</article-title><source>Med Sci Sports Exerc</source><year>1998</year><volume>30</volume><fpage>1572</fpage><lpage>1577</lpage><pub-id pub-id-type="pmid">9813868</pub-id><pub-id pub-id-type="doi">10.1097/00005768-199811000-00003</pub-id></citation></ref><ref id="B6"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cirkel</surname><given-names>JW</given-names></name><name><surname>Klaassen</surname><given-names>WRC</given-names></name><name><surname>Kunst</surname><given-names>JA</given-names></name><name><surname>Aarns</surname><given-names>TEM</given-names></name><name><surname>Plag</surname><given-names>EC</given-names></name><name><surname>Goudswaard</surname><given-names>AN</given-names></name><name><surname>Burgers</surname><given-names>JS</given-names></name></person-group><article-title>Niet-Traumatische knieproblemen bij kinderen en adolescenten; NHG-Standaard</article-title><source>Huisarts Wet</source><year>1998</year><volume>41</volume><fpage>246</fpage><lpage>251</lpage></citation></ref><ref id="B7"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Heintjes</surname><given-names>E</given-names></name><name><surname>Berger</surname><given-names>MY</given-names></name><name><surname>Bierma-Zeinstra</surname><given-names>SM</given-names></name><name><surname>Bernsen</surname><given-names>RM</given-names></name><name><surname>Verhaar</surname><given-names>JA</given-names></name><name><surname>Koes</surname><given-names>BW</given-names></name></person-group><article-title>Exercise therapy for patellofemoral pain syndrome</article-title><source>Cochrane Database Syst Rev</source><year>2003</year><fpage>CD003472</fpage><pub-id pub-id-type="pmid">14583980</pub-id></citation></ref><ref id="B8"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Crossley</surname><given-names>K</given-names></name><name><surname>Bennell</surname><given-names>K</given-names></name><name><surname>Green</surname><given-names>S</given-names></name><name><surname>Cowan</surname><given-names>S</given-names></name><name><surname>McConnell</surname><given-names>J</given-names></name></person-group><article-title>Physical therapy for patellofemoral pain: a randomized, double-blinded, placebo-controlled trial</article-title><source>Am J Sports Med</source><year>2002</year><volume>30</volume><fpage>857</fpage><lpage>865</lpage><pub-id pub-id-type="pmid">12435653</pub-id></citation></ref><ref id="B9"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Clark</surname><given-names>DI</given-names></name><name><surname>Downing</surname><given-names>N</given-names></name><name><surname>Mitchell</surname><given-names>J</given-names></name><name><surname>Coulson</surname><given-names>L</given-names></name><name><surname>Syzpryt</surname><given-names>EP</given-names></name><name><surname>Doherty</surname><given-names>M</given-names></name></person-group><article-title>Physiotherapy for anterior knee pain: a randomised controlled trial</article-title><source>Ann Rheum Dis</source><year>2000</year><volume>59</volume><fpage>700</fpage><lpage>704</lpage><pub-id pub-id-type="pmid">10976083</pub-id><pub-id pub-id-type="doi">10.1136/ard.59.9.700</pub-id></citation></ref><ref id="B10"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Van Der Heijden</surname><given-names>GJ</given-names></name><name><surname>Leffers</surname><given-names>P</given-names></name><name><surname>Wolters</surname><given-names>PJ</given-names></name><name><surname>Verheijden</surname><given-names>JJ</given-names></name><name><surname>van Mameren</surname><given-names>H</given-names></name><name><surname>Houben</surname><given-names>JP</given-names></name><name><surname>Bouter</surname><given-names>LM</given-names></name><name><surname>Knipschild</surname><given-names>PG</given-names></name></person-group><article-title>No effect of bipolar interferential electrotherapy and pulsed ultrasound for soft tissue shoulder disorders: a randomised controlled trial</article-title><source>Ann Rheum Dis</source><year>1999</year><volume>58</volume><fpage>530</fpage><lpage>540</lpage><pub-id pub-id-type="pmid">10460185</pub-id></citation></ref><ref id="B11"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kujala</surname><given-names>UM</given-names></name><name><surname>Jaakkola</surname><given-names>LH</given-names></name><name><surname>Koskinen</surname><given-names>SK</given-names></name><name><surname>Taimela</surname><given-names>S</given-names></name><name><surname>Hurme</surname><given-names>M</given-names></name><name><surname>Nelimarkka</surname><given-names>O</given-names></name></person-group><article-title>Scoring of patellofemoral disorders</article-title><source>Arthroscopy</source><year>1993</year><volume>9</volume><fpage>159</fpage><lpage>163</lpage><pub-id pub-id-type="pmid">8461073</pub-id></citation></ref><ref id="B12"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Crossley</surname><given-names>KM</given-names></name><name><surname>Bennell</surname><given-names>KL</given-names></name><name><surname>Cowan</surname><given-names>SM</given-names></name><name><surname>Green</surname><given-names>S</given-names></name></person-group><article-title>Analysis of outcome measures for persons with patellofemoral pain: which are reliable and valid?</article-title><source>Arch Phys Med Rehabil</source><year>2004</year><volume>85</volume><fpage>815</fpage><lpage>822</lpage><pub-id pub-id-type="pmid">15129407</pub-id><pub-id pub-id-type="doi">10.1016/S0003-9993(03)00613-0</pub-id></citation></ref><ref id="B13"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Brouwer</surname><given-names>WB</given-names></name><name><surname>Koopmanschap</surname><given-names>MA</given-names></name><name><surname>Rutten</surname><given-names>FF</given-names></name></person-group><article-title>Productivity losses without absence: measurement validation and empirical evidence</article-title><source>Health Policy</source><year>1999</year><volume>48</volume><fpage>13</fpage><lpage>27</lpage><pub-id pub-id-type="pmid">10539583</pub-id><pub-id pub-id-type="doi">10.1016/S0168-8510(99)00028-7</pub-id></citation></ref><ref id="B14"><citation citation-type="book"><person-group person-group-type="author"><name><surname>Diggle</surname><given-names>PJ</given-names></name><name><surname>Liang</surname><given-names>KY</given-names></name><name><surname>Zeger</surname><given-names>SL</given-names></name></person-group><source>Analysis of Longitudinal Data</source><year>1994</year><publisher-name>Oxford, Clarendon Press</publisher-name></citation></ref><ref id="B15"><citation citation-type="book"><person-group person-group-type="author"><name><surname>Oostenbrink</surname><given-names>JB</given-names></name><name><surname>Koopmanschap</surname><given-names>MA</given-names></name><name><surname>Rutten</surname><given-names>FFH</given-names></name></person-group><source>Handleiding voor kostenonderzoek; methoden en richtlijnprijzen voor economische evaluaties in de gezondheidszorg</source><year>2000</year><volume>1</volume><publisher-name>Amstelveen, College voor zorgverzekeringen</publisher-name></citation></ref><ref id="B16"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jacob-Tacken</surname><given-names>KH</given-names></name><name><surname>Koopmanschap</surname><given-names>MA</given-names></name><name><surname>Meerding</surname><given-names>WJ</given-names></name><name><surname>Severens</surname><given-names>JL</given-names></name></person-group><article-title>Correcting for compensating mechanisms related to productivity costs in economic evaluations of health care programmes</article-title><source>Health Econ</source><year>2005</year><volume>14</volume><fpage>435</fpage><lpage>443</lpage><pub-id pub-id-type="pmid">15497201</pub-id><pub-id pub-id-type="doi">10.1002/hec.948</pub-id></citation></ref><ref id="B17"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>van Roijen</surname><given-names>L</given-names></name><name><surname>Essink-Bot</surname><given-names>ML</given-names></name><name><surname>Koopmanschap</surname><given-names>MA</given-names></name><name><surname>Bonsel</surname><given-names>G</given-names></name><name><surname>Rutten</surname><given-names>FF</given-names></name></person-group><article-title>Labor and health status in economic evaluation of health care. The Health and Labor Questionnaire</article-title><source>Int J Technol Assess Health Care</source><year>1996</year><volume>12</volume><fpage>405</fpage><lpage>415</lpage><pub-id pub-id-type="pmid">8840661</pub-id></citation></ref><ref id="B18"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Koopmanschap</surname><given-names>MA</given-names></name></person-group><article-title>PRODISQ: a modular questionnaire on productivity and disease for economic evaluation studies</article-title><source>Expert Rev Pharmacoeconomics Outcomes Res</source><year>2005</year><volume>5</volume><fpage>23</fpage><lpage>28</lpage><pub-id pub-id-type="doi">10.1586/14737167.5.1.23</pub-id></citation></ref><ref id="B19"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Koopmanschap</surname><given-names>MA</given-names></name><name><surname>Rutten</surname><given-names>FF</given-names></name><name><surname>van Ineveld</surname><given-names>BM</given-names></name><name><surname>van Roijen</surname><given-names>L</given-names></name></person-group><article-title>The friction cost method for measuring indirect costs of disease</article-title><source>J Health Econ</source><year>1995</year><volume>14</volume><fpage>171</fpage><lpage>189</lpage><pub-id pub-id-type="pmid">10154656</pub-id><pub-id pub-id-type="doi">10.1016/0167-6296(94)00044-5</pub-id></citation></ref><ref id="B20"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Brooks</surname><given-names>R</given-names></name></person-group><article-title>EuroQol: the current state of play</article-title><source>Health Policy</source><year>1996</year><volume>37</volume><fpage>53</fpage><lpage>72</lpage><pub-id pub-id-type="pmid">10158943</pub-id><pub-id pub-id-type="doi">10.1016/0168-8510(96)00822-6</pub-id></citation></ref><ref id="B21"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dolan</surname><given-names>P</given-names></name><name><surname>Gudex</surname><given-names>C</given-names></name><name><surname>Kind</surname><given-names>P</given-names></name><name><surname>Williams</surname><given-names>A</given-names></name></person-group><article-title>The time trade-off method: results from a general population study</article-title><source>Health Econ</source><year>1996</year><volume>5</volume><fpage>141</fpage><lpage>154</lpage><pub-id pub-id-type="pmid">8733106</pub-id><pub-id pub-id-type="doi">10.1002/(SICI)1099-1050(199603)5:2&lt;141::AID-HEC189&gt;3.0.CO;2-N</pub-id></citation></ref><ref id="B22"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lamers</surname><given-names>LM</given-names></name><name><surname>Stalmeier</surname><given-names>PF</given-names></name><name><surname>McDonnell</surname><given-names>J</given-names></name><name><surname>Krabbe</surname><given-names>PF</given-names></name><name><surname>van Busschbach</surname><given-names>JJ</given-names></name></person-group><article-title>[Measuring the quality of life in economic evaluations: the Dutch EQ-5D tariff]</article-title><source>Ned Tijdschr Geneeskd</source><year>2005</year><volume>149</volume><fpage>1574</fpage><lpage>1578</lpage><pub-id pub-id-type="pmid">16038162</pub-id></citation></ref></ref-list><sec sec-type="display-objects"><title>Figures and Tables</title><fig position="float" id="F1"><label>Figure 1</label><caption><p>Flowchart of the study design.</p></caption><graphic xlink:href="1471-2474-7-31-1"></graphic></fig><fig position="float" id="F2"><label>Figure 2</label><caption><p>Sheet from the workout book with example exercises.</p></caption><graphic xlink:href="1471-2474-7-31-2"></graphic></fig><table-wrap position="float" id="T1"><label>Table 1</label><caption><p>Questionnaires for primary and secondary outcome measurements</p></caption><table frame="hsides" rules="groups"><tbody><tr><td align="left" colspan="3"><bold>Primary outcome measurements</bold></td></tr><tr><td align="left">Perceived recovery</td><td align="left">-</td><td align="left">Likert scale</td></tr><tr><td align="left">Functional disability</td><td align="left">-</td><td align="left">Kujala Patellofemoral Scale</td></tr><tr><td align="left">Pain Severity</td><td align="left">-</td><td align="left">Numerical Rating Scale (NRS)</td></tr><tr><td align="left" colspan="3"><bold>Secondary outcome measurements</bold></td></tr><tr><td align="left">Direct medical costs</td><td align="left">-</td><td align="left">Healthcare consumption</td></tr><tr><td align="left">Productivity costs</td><td align="left">-</td><td align="left">PRODISQ</td></tr><tr><td align="left">Health(improvement)</td><td align="left">-</td><td align="left">EuroQol</td></tr></tbody></table></table-wrap></sec></back></article>